Opportunity Information: Apply for CDC RFA GH15 1548
Apply for CDC RFA GH15 1548
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Supporting HIV and Tuberculosis Response in the Kingdom of Lesotho through District based Comprehensive Prevention, Care and Treatment Programs and Health Systems Strengthening under the Presidents Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Sep 11, 2014 and posted on Sep 11, 2014.
- Applicants must submit their applications by Oct 24, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $5,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible applicants that can apply for this FOA are listed below Government Organizations National Ministries of Health State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) . American Indian/Alaska Native tribal governments (federally recognized or state recognized) Political subdivisions of States (in consultation with States) Non government Organizations American Indian/Alaska native tribally designated organizations Alaska Native health corporations Tribal epidemiology centers Urban Indian health organizations Nonprofit with 501C3 IRS status (other than institution of higher education) Nonprofit without 501C3 IRS status (other than institution of higher education) Research institutions (that will perform activities deemed as non research) Colleges and Universities Community based organizations Faith based organizations
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This CDC funding opportunity (CDC RFA GH15-1548) supports PEPFAR efforts in the Kingdom of Lesotho to scale up comprehensive, district-based HIV and tuberculosis (TB) prevention, care, and treatment services while strengthening local health systems. Lesotho faces a severe, generalized HIV epidemic with major gender differences in risk and outcomes, and it also has one of the highest TB/HIV coinfection burdens globally. With a national population of about 1.9 million, UNAIDS (2012) estimated more than 360,000 people living with HIV, including roughly 38,000 children under 15. Even with this heavy burden, the country made measurable progress in reducing AIDS-related deaths, dropping from around 26,000 in 2005 to under 16,000 in 2012. The grant is intended to build on that progress by intensifying high-impact interventions at district level in a coordinated way.
The overall goal is to use a district model to accelerate the delivery of HIV prevention and treatment interventions in four priority districts, with the stated ambition of moving toward an AIDS-free generation. The four service districts are Leribe, Berea, Quthing, and Qacha's Nek, which together have an estimated population of about 750,000 people. The program is designed to align with the Lesotho National HIV/AIDS Strategic Plan, meaning funded activities should reinforce national priorities rather than operate as stand-alone projects.
Programmatically, the FOA focuses on expanding routine HIV case identification and ensuring people do not fall through gaps between diagnosis and treatment. A central component is scaling up provider-initiated testing and counseling (PITC) in health facility settings, along with stronger linkage-to-care systems so that individuals who test positive are promptly enrolled into HIV services and started on appropriate treatment. The opportunity also emphasizes prevention of mother-to-child transmission (PMTCT), with a specific target of reducing transmission to below 5 percent and improving the survival of both mothers and infants by keeping mother-baby pairs engaged in care. Alongside this, the FOA prioritizes increasing antiretroviral therapy (ART) coverage more broadly, both to reduce AIDS-related mortality and to lower onward HIV transmission through viral suppression.
Given Lesotho's high TB/HIV coinfection rates, TB/HIV integration is a major pillar of the work. The FOA calls for ensuring that all people diagnosed with TB/HIV coinfection are initiated on ART and retained in care, which implies not only starting treatment but also improving follow-up systems, adherence support, and coordinated service delivery between TB and HIV programs. Retention and continuity of care are treated as essential outcomes because starting ART alone does not deliver population-level impact without sustained engagement and viral suppression.
A key health systems strengthening objective is building the capacity of District Health Management Teams (DHMTs) to routinely deliver high-quality HIV programs. In practical terms, this typically involves improving district-level planning and management, supervision and mentoring of facilities, data use for decision-making, supply chain and laboratory coordination, and quality improvement processes so that service delivery gains can be maintained beyond the life of the award. The FOA frames DHMT strengthening as necessary for making HIV and TB services consistently effective across facilities in each district, rather than dependent on short-term external support.
The award mechanism is a cooperative agreement, which generally means CDC expects substantial programmatic involvement and collaboration during implementation, rather than a purely hands-off grant. The activity category is health, and the CFDA number listed is 93.067 (Global AIDS). The FOA anticipated a single award (ExpectedAwards: 1) with an award ceiling of $5,000,000. No cost sharing or matching is required. The posting date was September 11, 2014, and the application closing date was October 24, 2014, with an archive date of November 23, 2014.
Eligibility is broad and includes a mix of government and non-government entities. Eligible applicants include national ministries of health; state and local governments and their bona fide agents (including specified U.S. territories and freely associated states); American Indian/Alaska Native tribal governments; political subdivisions of states (in consultation with states); and a wide range of non-government organizations such as tribally designated organizations, Alaska Native health corporations, tribal epidemiology centers, urban Indian health organizations, nonprofits with or without 501(c)(3) status (excluding institutions of higher education in those particular categories), community-based and faith-based organizations, colleges and universities, and research institutions when carrying out activities considered non-research. For access issues related to the full announcement, the contact provided is the CDC Procurement and Grants Office Technical Information Management Section (770-488-2700).
Frequently Asked Questions (FAQs)
What is this funding opportunity?
This is a CDC funding opportunity announcement (CDC RFA GH15-1548) that supports PEPFAR efforts in the Kingdom of Lesotho to scale up comprehensive, district-based HIV and tuberculosis (TB) prevention, care, and treatment services, while strengthening local health systems.
What is the overall goal of the program?
The overall goal is to use a district model to accelerate delivery of HIV prevention and treatment interventions in four priority districts in Lesotho, with the stated ambition of moving toward an AIDS-free generation. Funded activities are intended to align with the Lesotho National HIV/AIDS Strategic Plan.
Which districts are included in the program?
The four priority service districts are Leribe, Berea, Quthing, and Qacha's Nek.
What population does the program cover?
The four service districts together have an estimated population of about 750,000 people.
Why is this opportunity focused on Lesotho?
Lesotho faces a severe, generalized HIV epidemic with major gender differences in risk and outcomes, and it also has one of the highest TB/HIV coinfection burdens globally. With a national population of about 1.9 million, UNAIDS (2012) estimated more than 360,000 people living with HIV, including roughly 38,000 children under 15.
What progress is this grant intended to build on?
Even with a heavy HIV burden, Lesotho made measurable progress in reducing AIDS-related deaths, decreasing from around 26,000 in 2005 to under 16,000 in 2012. The grant is intended to build on that progress by intensifying high-impact interventions at district level in a coordinated way.
What are the main programmatic priorities described in the FOA?
The FOA emphasizes expanding routine HIV case identification, strengthening linkage-to-care so people do not fall through gaps between diagnosis and treatment, improving PMTCT outcomes, increasing ART coverage and viral suppression, integrating TB/HIV services, and improving retention and continuity of care.
What does the FOA say about HIV testing and case identification?
A central component is scaling up provider-initiated testing and counseling (PITC) in health facility settings, along with stronger linkage-to-care systems so individuals who test positive are promptly enrolled into HIV services and started on appropriate treatment.
What does the opportunity emphasize about linkage to care after a positive HIV test?
The opportunity emphasizes stronger linkage-to-care systems so that individuals who test positive are promptly enrolled into HIV services and started on appropriate treatment, helping prevent drop-offs between diagnosis and treatment initiation.
How is PMTCT addressed in this opportunity?
Prevention of mother-to-child transmission (PMTCT) is a priority, with a specific target of reducing transmission to below 5 percent and improving the survival of both mothers and infants by keeping mother-baby pairs engaged in care.
What does the FOA prioritize related to antiretroviral therapy (ART)?
The FOA prioritizes increasing ART coverage to reduce AIDS-related mortality and to lower onward HIV transmission through viral suppression.
How does the FOA address TB/HIV coinfection?
TB/HIV integration is a major pillar. The FOA calls for ensuring that all people diagnosed with TB/HIV coinfection are initiated on ART and retained in care, implying improvements in follow-up systems, adherence support, and coordinated service delivery between TB and HIV programs.
Why is retention and continuity of care emphasized?
Retention and continuity of care are treated as essential outcomes because starting ART alone does not deliver population-level impact without sustained engagement and viral suppression.
What health systems strengthening activities are highlighted?
A key objective is building the capacity of District Health Management Teams (DHMTs) to routinely deliver high-quality HIV programs. The FOA describes strengthening district-level planning and management, supervision and mentoring of facilities, data use for decision-making, supply chain and laboratory coordination, and quality improvement processes to help maintain gains beyond the award period.
What is the role of District Health Management Teams (DHMTs) in this program?
DHMT strengthening is framed as necessary for making HIV and TB services consistently effective across facilities in each district, rather than dependent on short-term external support.
What type of award mechanism is used?
The award mechanism is a cooperative agreement, which generally means CDC expects substantial programmatic involvement and collaboration during implementation rather than a purely hands-off grant.
What is the activity category and CFDA number?
The activity category is health, and the CFDA number listed is 93.067 (Global AIDS).
How many awards were expected?
The FOA anticipated a single award (ExpectedAwards: 1).
What is the maximum funding amount available?
The award ceiling listed is $5,000,000.
Is cost sharing or matching required?
No. The FOA states that no cost sharing or matching is required.
When was the opportunity posted and when did it close?
The posting date was September 11, 2014. The application closing date was October 24, 2014.
When was the opportunity archived?
The archive date was November 23, 2014.
Who is eligible to apply?
Eligibility is broad and includes government and non-government entities. Eligible applicants include national ministries of health; state and local governments and their bona fide agents (including specified U.S. territories and freely associated states); American Indian/Alaska Native tribal governments; political subdivisions of states (in consultation with states); and a range of non-government organizations such as tribally designated organizations, Alaska Native health corporations, tribal epidemiology centers, urban Indian health organizations, nonprofits with or without 501(c)(3) status (excluding institutions of higher education in those particular categories), community-based and faith-based organizations, colleges and universities, and research institutions when carrying out activities considered non-research.
Are colleges and universities eligible?
Yes. The eligibility list includes colleges and universities.
Are nonprofits eligible even if they do not have 501(c)(3) status?
Yes. The eligibility description includes nonprofits with or without 501(c)(3) status, with a noted exclusion applying to institutions of higher education in those particular nonprofit categories.
Are community-based and faith-based organizations eligible?
Yes. The eligibility list explicitly includes community-based and faith-based organizations.
Are research institutions eligible?
Yes, research institutions are included when carrying out activities considered non-research.
Who should be contacted for access issues related to the full announcement?
For access issues related to the full announcement, contact the CDC Procurement and Grants Office Technical Information Management Section at 770-488-2700.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Technical Assistance for Laboratory Systems Strengthening in Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR)
Previous opportunity: Strengthening the Capacity of the Republican AIDS Center to Implement HIV Program in the Republic of Tajikistan under the Presidents Emergency Plan for AIDS Relief (PEPFAR)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH15 1548
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH15 1548) also looked into and applied for these:
| Funding Opportunity |
|---|
| Technical Assistance for Laboratory Systems Strengthening in Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1560 Funding Number: CDC RFA GH15 1560 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| Request to Access Parkinsons Disease Related Biospecimens (X01) Apply for PAR 14 340 Funding Number: PAR 14 340 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Epigenetic Analyses of Aging as a Risk Factor for Multiple Chronic Conditions (U34) Apply for RFA AG 15 004 Funding Number: RFA AG 15 004 Agency: National Institutes of Health Category: Health Funding Amount: $600,000 |
| NIAID Career Transition Award (K22) Apply for PAR 14 341 Funding Number: PAR 14 341 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical and Translational Science Award (U54) Apply for RFA TR 14 009 Funding Number: RFA TR 14 009 Agency: National Institutes of Health Category: Health Funding Amount: $10,000,000 |
| Immunization Information Systems (IIS) Apply for CDC RFA IP13 130203CONT15 Funding Number: CDC RFA IP13 130203CONT15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Capacity Building of Provincial Health Directorates (DPSs) in Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1561 Funding Number: CDC RFA GH15 1561 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Strengthening the Delivery, Coordination, and Monitoring of HIV Services in Malawi through Faith based Institutions under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1550 Funding Number: CDC RFA GH15 1550 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,100,000 |
| South African University based Technical Assistance Aimed at Improving the quality of HIV/AIDS and related services in the Republic of South Africa under the United States Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1574 Funding Number: CDC RFA GH15 1574 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Improving Medical Education in Malawi under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1552 Funding Number: CDC RFA GH15 1552 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,000,000 |
| Support of Civil Registration and Vital Statistics in Malawi through the National Registration Bureau under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1554 Funding Number: CDC RFA GH15 1554 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,000,000 |
| Building Effective Health Information Systems under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1535 Funding Number: CDC RFA GH15 1535 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,600,000 |
| Technical Assistance and Support for the Development and Implementation of Key Aspects of HIV/AIDS Care and Support Services in South Africa under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1578 Funding Number: CDC RFA GH15 1578 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $6,500,000 |
| Peer to Peer Capacity Building in the Public Sector to Support Management, Leadership, and Sustainability of HIV Programs in PEPFAR Countries under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1532 Funding Number: CDC RFA GH15 1532 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,000,000 |
| Namibia Mechanism for Public Health Assistance, Capacity, and Technical Support (NAM PHACTS) under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1615 Funding Number: CDC RFA GH15 1615 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Analyses of Datasets on Older Populations with High Prevalence of Mobility Disability to Develop Clinically Meaningful Diagnostic Cut Points for Low Muscle Mass and/or Low Muscle Strength (U01) Apply for RFA AG 15 013 Funding Number: RFA AG 15 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Service Area Competition Apply for HRSA 15 012 Funding Number: HRSA 15 012 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competition Apply for HRSA 15 013 Funding Number: HRSA 15 013 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| NIDCR Behavioral or Social Intervention Clinical Trial Planning Grant (R34) Apply for PAR 14 342 Funding Number: PAR 14 342 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| NIDCR Clinical Trial or Biomarker Clinical Validation Study Planning Grant (R34) Apply for PAR 14 346 Funding Number: PAR 14 346 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH15 1548", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.